Daniel Lochner's most recent trade in Tectonic Therapeutic Inc. was a trade of 26,500 Common Stock done . Disclosure was reported to the exchange on March 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tectonic Therapeutic Inc | Daniel Lochner | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 26,500 | 58,544 | - | 0 | Common Stock | |
| Tectonic Therapeutic Inc | Daniel Lochner | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 24,250 | 24,250 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Daniel Lochner | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 21.61 per share. | 10 Feb 2026 | 6,000 | 32,044 | - | 21.6 | 129,660 | Common Stock |
| Tectonic Therapeutic Inc | Daniel Lochner | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.22 per share. | 04 Feb 2026 | 2,077 | 26,044 | - | 23.2 | 48,228 | Common Stock |
| Tectonic Therapeutic Inc | Daniel Lochner | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2025 | 9,860 | 9,860 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Daniel Lochner | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2025 | 5,430 | 28,121 | - | 0 | Common Stock | |
| Tectonic Therapeutic Inc | Daniel Lochner | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 54.14 per share. | 05 Feb 2025 | 4,617 | 4,617 | - | 54.1 | 249,964 | Common Stock |
| Tectonic Therapeutic Inc | Daniel Lochner | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 32,862 | 32,862 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Daniel Lochner | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 18,074 | 18,074 | - | 0 | Common Stock | |
| Tectonic Therapeutic Inc | Daniel Lochner | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 118,000 | 118,000 | - | - | Employee Stock Option (Right to Buy) |